100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Clear and complete summary of Tumor Immunology (TI) $12.07   Add to cart

Summary

Clear and complete summary of Tumor Immunology (TI)

 13 views  1 purchase
  • Course
  • Institution

Clear and complete summary of Tumor Immunology/Clear and complete summary of Tumor Immunology (TI)

Preview 3 out of 19  pages

  • October 4, 2022
  • 19
  • 2020/2021
  • Summary
avatar-seller
Summary
How tumor glycans contribute to immune evasion in cancer

N-linked = Glycan linked to Asn (asparagin ofzo). O-linked = glycan linked to Ser or Thr. There are hybrid
and complex glycans. Glycosylation by glycosyltransferases occurs in the ER and in the Golgi apparatus.
Altered glycosylation  altered cell signalling pathways  cancer. Glycoproteins are common used
biomarkers for cancer diagnosis and prognosis. Glycosylation can cause avoiding of immune destruction.

Important tumor-associated glycans:

1. Upregulation of sialic acids




2. Appearance of truncated (shorter) O-glycans (MGL ligands)




Lectins are glycan receptors on immune cells (e.g. APCs). There are C-type (CLR = C-type Lectin
Receptor) and L-type Lectins (SigLecs). Various ligands for the C-type. Only sialic acid is a ligand for L-
type lectins (Siglec).

These lectins (glycan receptors) are inhibitory; they can dampen the immune response with ITIM motifs.
Sialic acid on glycans on the tumor cell can induce macrophage modulation  these macrophages will
produce TGF-b and IL-10  dampened immune response.
Hypersialyation (many sialic acids)  immune evasion of tumor cells because sialic acid induces Treg
differentiation by DCs (Th1  Treg shift).




Solution: inhibit/KO the sialic acid transporter that pumps SA into the golgi  less SA in golgi  less SA
can be added to the cell surface by glycosyltransferases.

Summary

 Lectins are inhibitory glycan receptors
 Siglec = L-Type lectin  sialic acid is ligand
 Sialic acid induces immunotolerance (more Tregs, less NK cell response) immune escape
 Glycosyltransferases perform glycosylation in the golgi apparatus

,Glycosylation changes in cancer

In melanoma (B16, right), high sialic acid leads to tumor growth,
because sialic acid induces immune tolerance (Tregs).

In colorectal cancer (MC38, left), no sialic acid leads to cancer.

These colorectal tumors (without Sialic acid) recruit less T cells and
even secrete factors that induce apoptosis of T cells (cold tumor).




C-type Lectin Receptor (CLR). C stands for calcium  Ca dependent recognition of specific glycan
structures. Also important in cell-cell adhesion. Selectins (C-type lectin) recognize glycans of bacteria
and viruses. Selectins degrade them  alter cytokine expression  determines the T cell response.

5 potential O-glycosylation sites. A lot of
glycans can be attached. In tumors they
become really short (truncated). These short
glycans are ligands for MGL (Macrophage
Galactose-type Lectin)  receptor on APCs in
skin and gut.

Tn- and Sialyl-Tn Ags are ligands for MGL.




In Colon carcinoma, MGL detects glycan changes on tumor-derived MUC1. MGL-MUC1 binding scores
(brown is very strong). Stage I & II  still in the colon. III is metastasis to LN. IV is metastasis to liver.
High binding of MGL to tumors means poor survival.

MGL triggering on DC leads to high IL-10 production and thus to anergic/regulatory T cells. Solution:
Anti-MGL  less IL-10 produced.


Summary

 Tn-antigen / Sialic-Tn-antigen / Mucins on cell surface
 dysregulation of immunity, escape from immune surveillance, progression and metastasis
 Tumors/Pathogens use glycans to escape the immune response
 Melanoma  high sialic acid leads to cancer due to immune tolerance
 CRC  no sialic acid leads to T cell apoptosis and thus to cancer.
 Selectins optimize/fine-tune the immune response
 High MGL-MUC1 binding in CRC = poor survival

, Transcriptional immune profiles for cancer prognosis and therapy selection !’s checken in PP

Immuno-Editing = Elimination (immunosurveillance)  equilibrium  escape. Tumor cells that are
weakly immunogenic are able to escape. Tumor cells that are strongly immunogenic are destructed.

Immune profiling (e.g. by a biopsy) can identify biomarkers

 prognostic (predict survival irrespective of treatment)
o Patients WITH 12-chemokine (signature) lived longer
 predictive (predict clinical outcome/survival on a specific treatment) biomarkers
o Randomized clinical trial necessary

A liquid biopsy is better than a traditional biopsy because it is taken out of the blood (more cells to
investigate), it is less painful and easier to obtain (more often).

Endogenous IFN-beta signalling is required for intratumoral
accumulation & migration of (cross-priming) CD8α+ DCs.




DAMPs
and PAMPs trigger IFN-I gene transcription via the (Stimulator
of Interferon genes) (STING pathway. dsDNA is sensed in the
cytoplasm. Check IFN-induction @next page.




When a patient gets chemotherapy (e.g. doxorubicin), the tumor cell expresses Calreticulin (CRT) on the
outside (normally on the inside of cell)  “come eat me” sign to immune cells. MHGB1 (a protein with a
high mobility) is then released by the tumor cell and binds to a DC  DC activation  T cell activation
 tumor cell apoptosis.

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller SophiedBoer. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $12.07. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

76669 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$12.07  1x  sold
  • (0)
  Add to cart